Midwest Bioprocessing Center Selected for gBETA Distillery Labs Spring 2025 Accelerator Program
Peoria, IL – April 22, 2025 — Midwest Bioprocessing Center (MBC), an innovator in sustainable biomanufacturing technologies, is pleased to announce its selection for the prestigious gBETA Distillery Labs accelerator, managed by nationally acclaimed startup accelerator gener8tor.
gBETA Distillery Labs is an intensive accelerator program providing access to gener8tor’s extensive network of mentors, investors, corporate partners, and customers. The program culminates in a showcase event scheduled for summer 2025, where startup founders will present their companies to investors and community leaders.
“We are honored to be chosen for the gBETA Distillery Labs accelerator program,” said Dr. David Demirjian, Founder and CEO of Midwest Bioprocessing Center. “This opportunity significantly enhances our ability to connect with strategic partners, investors, and industry leaders, accelerating our growth and enabling broader adoption of our innovative bioprocessing technologies.”
Midwest Bioprocessing Center is renowned for its FeruliShield™ platform, a revolutionary, bio-based antioxidant designed to naturally boost the SPF of skincare products, protect formulations from environmental damage, and enhance the shelf-life and effectiveness of active ingredients. With multiple issued and pending patents, FeruliShield™ provides a sustainable solution for luxury and clean-beauty brands seeking to elevate their product formulations.
For additional information on Midwest Bioprocessing Center, please visit www.mwbioprocessing.com. To learn more about gener8tor and the gBETA Distillery Labs program, visit www.gener8tor.com/gbeta.
Media Contact: Elena Chaikin
Marketing Manager
Midwest Bioprocessing Center
echaikin@mwbioprocessing.com
